We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Releases New Draft Guidances on Gene Therapies
FDA Releases New Draft Guidances on Gene Therapies
The FDA unveiled six new draft guidances outlining its latest thinking on the rapidly evolving field of gene therapy — and Commissioner Scott Gottlieb said the agency plans to work with product sponsors to help make the development and approval of innovative gene therapies more efficient.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor